Shenzhen Edge Medical Co (HKSE:02675) Altman Z2-Score: 9.94 (As of Aug. 14, 2026) — 38% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02675 Shenzhen Edge Medical Co Ltd HKSE:02675
11 GF Score
Price HK$38.30
! 3 Warning Signs
View Full Analysis

What is Shenzhen Edge Medical Co Altman Z2-Score?

Shenzhen Edge Medical Co HKSE:02675 -3.14% 11 Altman Z2-Score is 9.94 as of Aug. 14, 2026, which is 38% below its 10-year median of 16.00. GuruFocus rates HKSE:02675 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks better than 83.45% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Shenzhen Edge Medical Co has a Altman Z2-Score of 9.94, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Shenzhen Edge Medical Co's Altman Z2-Score or its related term are showing as below:

HKSE:02675' s Altman Z2-Score Range Over the Past 10 Years
Min: 9.94   Med: 16   Max: 16.27
Current: 9.94

During the past 3 years, Shenzhen Edge Medical Co's highest Altman Z2-Score was 16.27. The lowest was 9.94. And the median was 16.00.


Shenzhen Edge Medical Co  (HKSE:02675) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Shenzhen Edge Medical Co Altman Z2-Score Related Terms


Shenzhen Edge Medical Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Shenzhen Edge Medical Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Edge Medical Co Altman Z2-Score Chart

Shenzhen Edge Medical Co Annual Data
Trend Dec23 Dec24 Dec25
Altman Z2-Score
16.27 16.00 9.94

Shenzhen Edge Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score 16.27 0.00 16.00 0.00 9.94

HKSE:02675 vs ABT, SYK, MDT: Altman Z2-Score Comparison

For the Medical Devices subindustry, Shenzhen Edge Medical Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Edge Medical Co Altman Z2-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Shenzhen Edge Medical Co's Altman Z2-Score falls into.


HKSE:02675
11GF Score
Shenzhen Edge Medical Co Ltd HKSE:02675
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Edge Medical Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Shenzhen Edge Medical Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.8442+3.26*-0.5843+6.72*-0.0636+1.05*6.4092
=9.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$1,530.9 Mil.
Total Current Assets was HK$1,474.1 Mil.
Total Current Liabilities was HK$181.7 Mil.
Retained Earnings was HK$-894.5 Mil.
Pre-Tax Income was HK$-97.9 Mil.
Interest Expense was HK$-0.6 Mil.
Total Liabilities was HK$206.6 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1474.091 - 181.667)/1530.862
=0.8442

X2=Retained Earnings/Total Assets
=-894.53/1530.862
=-0.5843

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-97.886 - -0.598)/1530.862
=-0.0636

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1324.245 - 0)/206.617
=6.4092

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Shenzhen Edge Medical Co has a Altman Z2-Score of 9.94 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 9.94 mean?
Shenzhen Edge Medical Co (HKSE:02675) has a Altman Z2-Score of 9.94 as of Aug. 14, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Shenzhen Edge Medical Co and its competitors. This is 38% below median its historical median of 16.00. Over the past decade, Shenzhen Edge Medical Co's Altman Z2-Score has ranged from 9.94 to 16.27. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #139 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 16.5%.
Is Shenzhen Edge Medical Co's Altman Z2-Score too high?
Shenzhen Edge Medical Co's current Altman Z2-Score of 9.94 is 38% below median its 10-year median of 16.00. Over the past 10 years, this metric has ranged from a low of 9.94 to a high of 16.27. The Medical Devices & Instruments industry median Altman Z2-Score is 3.45. Shenzhen Edge Medical Co's value of 9.94 is 188.1% above this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #139 out of 840 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shenzhen Edge Medical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Altman Z2-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #139 out of 840 companies for Altman Z2-Score. This places Shenzhen Edge Medical Co in the top 17% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 3.45. Shenzhen Edge Medical Co's value of 9.94 is 188.1% above this benchmark. Historically, Shenzhen Edge Medical Co's own Altman Z2-Score has ranged from 9.94 to 16.27 over the past decade. While the company's 10-year median is 16.00 vs. the industry median of 3.45, Shenzhen Edge Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Medical Devices & Instruments company?
The median Altman Z2-Score among Medical Devices & Instruments companies is 3.45, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current Altman Z2-Score of 9.94 is 188.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z2-Score is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current Altman Z2-Score is 9.94, which is 38% below median its own 10-year median of 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (HKSE:02675) has a current Altman Z2-Score of 9.94. The current Altman Z2-Score is 9.94, which is 38% below median its 10-year median of 16.00 and 188.1% above the Medical Devices & Instruments industry median of 3.45. Shenzhen Edge Medical Co's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Shenzhen Edge Medical Co (HKSE:02675), the current Altman Z2-Score is 9.94 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenzhen Edge Medical Co Business Description

Other Exchanges R5Z:Germany
Address Baolong Street, Room 1901, Building 2B, Smart Park Phase II, Longgang District, Shenzhen, CHN
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
11GF Score

Get the complete analysis for HKSE:02675

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$38.30
Price